Gallahue Kieran
- SEC CIK
- 0001308428
No open-market purchases or sales filed in the past year.
Current role at each company
- NVST Envista Holdings CorpDirectoras of May 21, 2026
- EW Edwards Lifesciences CorpDirectoras of May 8, 2026
- XENT Intersect ENT, Inc.Directoras of May 16, 2022
- ARNA Arena Pharmaceuticals IncDirectoras of Mar 11, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Gallahue Kieran as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
EW Edwards Lifesciences Corp
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2024 (view filing) | Feb 23 | 3 days | Gallahue KieranDirector | SSale | −3.06K | $87.61 | −$267.9K | −4.4%67.2K after | |
| Feb 8, 2022 (view filing) | Feb 8 | Same day | Gallahue KieranDirector | SSale | −32.3K | $110.79 | −$3.57M | −90.4%3.43K after |